Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q37738012

about

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.How to treat borderline resectable pancreatic cancer: current challenges and future directions.

P2860

Q42375843-21D78F8E-B1E7-40EA-98FA-B5C55C99C5A4 Q47728528-B2924FD1-6241-42FE-9606-538E71B61DB9

P2860

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q37738012

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 April 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@en

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@nl

type

label

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@en

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@nl

prefLabel

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@en

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@nl

P1433

Q37738012-8BE08D3F-2D36-49B0-B728-46D41D901441

P1476

Q37738012-153AB4E0-D3B3-4540-8315-8E0452127318

P2093

Q37738012-0C5AD49E-7B6E-4879-84BF-5DFB5A6028F8

Q37738012-6C1133D0-3EE6-448F-BE28-FC83BAB4B023

Q37738012-77137AA3-6FD5-4341-8D94-391020883E62

Q37738012-7C6151F2-422F-4320-837D-2455D8DB899E

Q37738012-ACACD16F-DD82-4BAE-B3B4-64F38E264358

Q37738012-AEDE0B13-D79B-4CD4-A3F9-D6EE785AA3DB

Q37738012-BF6F71FF-F168-45E7-9A7C-814B174C98AC

P2860

Q37738012-0A8B46C2-3C0D-4FE1-BCF5-255E5BF45960

Q37738012-1746671A-F480-43AA-8D15-A218F7C7710D

Q37738012-214B1909-A8B9-4BB2-A0FF-D2102295B6F7

Q37738012-2ABAEC85-AC11-4471-AC38-542BF94C17D6

Q37738012-4F457270-3F13-41F8-8213-5E1F9A0C706A

Q37738012-57F7F638-1FE5-402A-921B-CE75719F62AF

Q37738012-5CE06E8B-A3EF-476F-B192-A99F2D2446D1

Q37738012-7800EB29-62AF-4D77-B568-110654B454A3

Q37738012-7BD2F385-89F6-4E2E-A61F-6B083873BF80

Q37738012-816548A2-B737-49FB-BA36-C525956B9131

P2888

Q37738012-B52E2D6D-D12F-481A-A9AC-4C22FB6431DD

P304

Q37738012-D3B0A982-1633-4879-BEB2-06988AC3CD9F

P31

Q37738012-5B02EE2A-3E42-45F7-8674-139FDD266B71

P356

Q37738012-5C0222A3-DFF6-4D41-93B9-83EFB12A57E4

P407

Q37738012-3018D310-AE29-4ECA-B742-E16225A69BED

P478

Q37738012-5C84F031-265D-4867-ADC9-6649553378DA

P50

Q37738012-16C7E2D1-386C-46F6-B8C2-6EC1F89C9686

Q37738012-3884A09F-7AA2-45C5-987D-EA45FCC89D76

Q37738012-95B85200-7F1D-4E12-9C9C-602E66A71E50

P577

Q37738012-984331E8-BAB3-461D-8A99-B90964F8CA97

P698

Q37738012-F93E3F0E-1ADE-4F0F-9C66-3F0CE857C103

P921

Q37738012-62FC98ED-589C-42BD-AEAC-739066578347

Q37738012-F23020FD-E63B-42AA-8D3E-7AC97B42F895

P932

Q37738012-6CE4B86D-550B-46C0-B26F-7628FE5738A0

P356

P1433

Scientific Reports

P1476

Phase II study of induction ch ...... ly advanced pancreatic cancer.

@en

P2093

Barnaba Floreno

http://www.w3.org/2001/XMLSchema#string

Luca Eolo Trodella

http://www.w3.org/2001/XMLSchema#string

Lucio Trodella

http://www.w3.org/2001/XMLSchema#string

Pasquale Trecca

http://www.w3.org/2001/XMLSchema#string

Rolando Maria D'Angelillo

http://www.w3.org/2001/XMLSchema#string

Sara Ramella

http://www.w3.org/2001/XMLSchema#string

Sergio Valeri

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer

Cancer statistics, 2016

Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinair

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials.

Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.

P2888

P304

45845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP45845

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Coppola

P577

2017-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28378800

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5381116

http://www.w3.org/2001/XMLSchema#string